Medical Professionals/
MD Learning Channel/
MDL CME/

MD Learning Channel - Free CME Opportunities

CME

Cancer

Cardiovascular

COVID-19

Endocrinology & Diabetes

Gastroenterology & Hepatology

Genetics

Medicine

Nephrology

Neurosciences

Obstetrics & Gynecology

Ophthalmology

Oral & Maxillofacial Surgery

Orthopaedics

Pain Management

Pulmonary, Allergy & Critical Care

Surgery

Transplant

Urology

ABDOMINAL AORTIC ANEURYSM

0.25
CME/CE

13
MINUTES

Abdominal Aortic Aneurysm

Release Date:
July 3, 2017
Reissue Date:
August 23, 2021

Expiration Date:
August 24, 2024

Target Audience:
Cardiologists and primary care physicians

Learning Objective / Overview: Adam Beck, MD, illustrates how grafts are successfully placed in complex abdominal aortic aneurysms with respect to type of grafts used and surrounding anatomy. After completion of the course, participants should be able to describe aortic aneurysms and their inherent risks to the patient. Additionally, participants should be able to discuss the contemporary treatment of aortic aneurysms.

Accreditation statement:The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure: Dr. Beck has no financial relationships related to the content of this activity to disclose. There is no commercial support for this activity.

Take Test Now >>

Autonomic Function Testing

0.25
CME/CE

19
MINUTES

AUTONOMIC FUNCTION TESTING

Release Date:

September 27, 2016

Re-Issue Date
May 6, 2020

Expiration Date:
May 6, 2023

Target Audience:
Neurologists and primary care physicians

Learning Objective / Overview: Autonomic function testing is the category of electrodiagnostic and clinical neurophysiology testing that is employed in the evaluation of sympathetic and parasympathetic neural pathways. Examining the integrity of these pathways is necessary in objectively evaluating many neurologic and cardiac conditions like orthostatic hypotension, recurrent syncopal episodes, and postural orthostatic tachycardia syndrome (POTS). Neurologists often time need to evaluate the functions of the thinly myelinated and non-myelinated small nerve fibers. These population of fibers cannot be assessed by routine nerve conduction studies or electromyography. The presence of autonomic dysfunction is a key criterion for the diagnosis of a life threatening condition like multiple system atrophy that distinguishes it from other more benign parkinsonian syndromes.

Accreditation Statement:The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure:

Planners:

Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical Education

Katelyn Hiden
Physician Marketing Manager, UAB Health System

The planners have no commercial affiliations to disclose.

Faculty:

Mohamed Kazamel, MD
Associate Professor of Medicine, UAB Department of Neurology

Dr. Kazamel has disclosed the following commercial interests:

Akcel Therapeutics, BioStealth Therapeutics – Consulting Fee

Dr. Kazamel does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose.

There is no commercial support for this activity.

Take Test Now >>

COVID-19: IMPACT OF THE CARDIOVASCULAR SYSTEM

1.0
CME/CE

51
MINUTES

COVID-19: Impact on the Cardiovascular System

COVID-19- Impact on the Cardiovascular System from UAB Health System on Vimeo.

Release Date:
May 20, 2020

Expiration Date:
May 20, 2023

Target Audience:
Cardiologists and primary care providers

Dr. Vera Bittner discusses COVID-19’s impact on the cardiovascular system.

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Understand the impact COVID-19 has to the cardiovascular system
Identify the impact COVID-19 has to pediatric cardiovascular systems.
Identify myocardial injury among hospitalized patients who are ill with COVID-19.

Disclosure: Dr. Bittner has the following financial relationships with commercial interests:

Grants/Grants Pending/Research Support - Amgen; Astra Zeneca; DalCor; Sanofi; Esperion; The Medicines Company
Consulting Fee - Sanofi
Honorarium - American College of Cardiology; American Heart Association; NIA DSMB
Payment for Lectures, including Service on Speakers' Bureaus - Mayo Clinic; National Lipid Association; Hartford Health

Dr. Bittner does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose.

There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Test Now >>

CELIAC DISEASE: FACT VS. FICTION

1.00

CME/CE

MINUTES

Celiac Disease: Fact vs. Fiction

Release Date:

September 8, 2021

Expiration Date:

September 7, 2024

Target Audience:

Gastroenterologists, surgeons, and primary care physicians

Learning Objective / Overview: Amanda Cartee, MD, Assistant Professor in the UAB Division of Gastroenterology & Hepatology, discusses common misconceptions about Celiac Disease, an immune-mediated inflammation of the small intestine that occurs with gluten exposure. She provides criteria to distinguish classical and non-classical symptoms and outlines four diagnostic criteria. She also describes three therapeutic goals for patients, specifically addressing pros and cons of a gluten-free diet.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Information:

Planners:

Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical Education

Katelyn Hiden
Physician Marketing Manager, UAB Health System

The planners have no relevant financial relationships with ineligible companies to disclose.

Speakers:

Amanda Cartee, MD
Assistant Professor in Hepatology, Internal Medicine

Dr. Cartee has no relevant financial relationships with ineligible companies to disclose.

There is no commercial support for this activity.

Take Test Now >>

Indications for Genetic Testing and Referral

0.25
CME/CE

20
MINUTES

Indications for Genetic Testing and Referral

Release Date:
August 1, 2019

Expiration Date:
August 1, 2022

Target Audience:
Genetic counselors and primary care physicians

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Identify and recognize suggestive findings related to the potential for cancer predisposition.
Identify and recognize when preconception or prenatal testing may be warranted or recommended.
Identify and recognize when referrals may be warranted for evaluating rare diseases/syndromes.

Disclosure: Dr. Hurst has the following financial relationships with commercial interests:

Grants/Research Support/Grants Pending - NIH, State of Alabama, Children's of Alabama
Support for travel to meetings or other purposes - Travel for meetings from Facial Dysmorphology Analysis

Dr. Hurst does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Test Now >>

GENETIC TEST RESULTS

0.25
CME/CE

17
MINUTES

Interpretation of Genetic Test Results

Release Date:
March 4, 2022

Expiration Date:
March 3, 2025

Target Audience:
Geneticists and primary care physicians

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Understand how laboratories determine if genetic variants are relevant to a person's health.
Understand the modern concept of precision medicine.

Disclosure Information:

Planners:

Ronan O’Beirne, EdD, MBA

Director, UAB Continuing Medical Education

Katelyn Hiden

Physician Marketing Manager, UAB Health System

The planners have no commercial affiliations to disclose.

Faculty:

Bruce Korf, MD

Chief Genomics Officer, Professor in Medical Genetics,

Dr. Korf has the following financial relationships with ineligible companies:

Consulting Fee - GenomeMedical, SpringWorks Therapeutics

Stock/shareholder - GenomeMedical

Honorarium - PeerView CME, Creative Educational Concepts

Board membership - American College of Medical Genetics and Genomics, American Society of Human Genetics

Payment for Development of Educational Presentations - PeerView CME, Creative Educational Concepts

Royalties - Elsevier, Wiley, UpToDate

Payment for Lectures, Including Service on Speakers Bureaus - PeerView CME, Creative Educational Concepts

All relevant financial relationships have been mitigated. Dr. Korf does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers (Ronan O'Beirne, EdD and Katelyn Hiden) have any relevant financial relationships to disclose.

There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Post Test >>

ACUTE KIDNEY INJURY IN COVID-19 PATIENTS

1.0
CME/CE

59
MIN

Managing Acute Kidney Injury in COVID-19 Patients

Managing Acute Kidney Injury in COVID-19 Patients from UAB Health System on Vimeo.

Release Date:
June 5, 2020

Expiration Date:
June 5, 2023

Target Audience:
Nephrologist, transplant surgeons, and primary care professionals

Dr. Ashita Tolwani discusses the management of acute kidney injury in COVID-19 patients.

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Understand how to manage acute kidney injury in patients with COVID-19
Identify best practices relating to acute kidney injury in patients with COVID-19
Understand continuous renal replacement therapy (CRRT)

Disclosure: Dr. Tolwani has the following financial relationships with commercial interests:

Consulting Fee - Baxter Healthcare
Patents (planned, pending or issued) - Royalties from Baxter for patent
Royalties - Royalties from Baxter for patent
Payment for Lectures, including Service on Speakers' Bureaus - Baxter Healthcare

Dr. Tolwani does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose. There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Test Now >>

Oral Oncology & Total Jaw Reconstruction

0.25
CME/CE

32
MINUTES

Oral Oncology and Total Jaw Reconstruction

Release Date:
November 15, 2019

Expiration Date:
November 15, 2022

Target Audience:
Surgeons and primary care physicians

In recent years, the oral and maxillofacial surgery field has seen significant advances in areas such as oral oncology and total jaw reconstruction. In this video, UAB Medicine surgeon Anthony Morlandt, MD, DDS, examines various minimally invasive, “free-flap”, and 3-D surgical techniques that may result in less scarring, improved outcomes, and decreased lengths of stay in the hospital.

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Speak to the current state of oral cancer in the country and in Alabama.
Understand the benefits of the reconstructive techniques for surgeons.
Speak to the vital goals of reconstruction from the patient’s perspective.
Describe the link between new technology and improved outcomes.

Disclosure: Dr. Morlandt has the following financial relationships with commercial interests:

Grants/Research Support/Grants Pending - OMS Foundation, Osteo Science Foundation
Honorarium - SORG North America, KLS Martin
Board Membership - Proteocycle Diagnostics Inc.

Dr. Morlandt does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose.

There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Test Now >>

PHARMACOGENOMICS: OPTIMIZING MEDICATION THERAPY

0.25

CME/CE

25 MINUTES

Pharmacogenomics: Optimizing Medication Therapy

Release Date:

May 16, 2022

Expiration Date:

May 15, 2025

Target Audience:
Health care professionals

Disclosure Information:

Planners:

Ronan O’Beirne, EdD, MBA

Director, UAB Continuing Medical Education

Katelyn Hiden

Physician Marketing Manager, UAB Health System

The planners have no relevant financial relationships with ineligible companies to disclose.

Faculty:

Nita Limdi, Pharm. D, PhD, MSPH, FAHA

Professor, Neurology & Epidemiology

Dr. Limdi has no relevant financial relationships with ineligible companies to disclose.

There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Post Test

The Rapid Development of COVID-19 Vaccines

1.0

CME/CE

MINUTES

THE RAPID DEVELOPMENT OF COVID-19 VACCINES

The Rapid Development of COVID-19 Vaccines from UAB Health System on Vimeo.

Release Date:
January 22, 2021

Expiration Date:
January 22, 2024

Target Audience:
Healthcare professionals

UAB Division of Infectious Diseases Professor Paul Goepfert, MD, discusses COVID-19 vaccine safety issues, effectiveness, and how it was developed in his Medical Grand Rounds presentation.

Disclosure Information:

Planners:
Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical EducationKatelyn Hiden
Physician Marketing Manager, UAB Health SystemThe planners have no commercial affiliations to disclose.

Presenters:
Paul Goepfert, MD
Professor, Division of Infectious Diseases

Dr. Goepfert has the following financial relationships with commercial interests:

Grants/Grants Pending/Research Support - Sanofi; NIH
Consulting Fee - Altimmune

No other speakers, planners, or content reviewers (Ronan O'Beirne, EdD, and Katelyn Hiden) have any relevant financial relationships to disclose. There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Test Now >>